Table 1.
ESRD patients, n = 1142 | |
---|---|
Age, years |
47.7 ± 13.5 |
Sex: male, n (%) |
662 (58.0) |
Primary disease: |
|
- glomerulonephritis, n (%) |
242 (21.2) |
- autosomal dominant polycystic kidney disease, n (%) |
155 (13.6) |
- pyelonephritis, n (%) |
128 (11.2) |
- renal vascular disease, n (%) |
110 (9.6) |
- IgA nephropathy, n (%) |
89 (7.8) |
- diabetes types I and II, n (%) |
47 (4.1) |
- other/uncertain etiology, n (%) |
371 (32.5) |
Kidney donors, n = 1184 |
|
Age, years |
44.5 ± 14.3 |
Sex: male, n (%) |
602 (50.8) |
Living donors, n (%) |
282 (23.8) |
- from which related donors, n (%) |
164 (58.2) |
Matched donor-recipient pairs, n = 1066 |
|
Recipient age, years |
48.1 ± 13.5 |
Recipient sex: male, n (%) |
620 (58.2) |
Donor age, years |
44.6 ± 14.3 |
Donor sex: male, n (%) |
540 (50.7) |
Living donors, n (%) |
261 (24.5) |
Cold ischemia time, hours |
17.4 [9.0-23.0] |
Total warm ischemia time, minutes |
40.0 [34.0-51.0] |
Delayed graft function, n (%) |
332 (31.1) |
Post-transplant follow-up duration, years |
5.5 [3.0-8.7] |
Acute organ rejection episodes history, n (%) |
368 (34.5) |
Death-censored graft failure, n (%) |
172 (16.1) |
Death with a functioning graft, n (%) |
182 (17.1) |
Renal transplant recipients with urine available, n = 282 |
|
Age, years |
52.1 ± 12.3 |
Sex: male, n (%) |
152 (53.9) |
Urine collection time point, years after transplantation | 4.2 [2.2-6.1] |
Continuous normally distributed variables are presented as means ± SD, non-normally distributed – as medians [IQR].